Adjuvant RT May Aid Men at High Risk for Death From Prostate Cancer
WEDNESDAY, June 16, 2021 -- For men with positive pelvic lymph nodes (pN1) or pGleason score 8 to 10 prostate cancer and disease extending beyond the prostate (pT3/4) at radical prostatectomy (RP), adjuvant radiation therapy (RT) versus early... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 16, 2021 Category: Pharmaceuticals Source Type: news
Accuray Expands CyberKnife(R) System Versatility with Integration of RaySearch's RayStation Treatment Planning System
Treatment Planning for the CyberKnife System and Other Radiation Therapy Devices Can Now be Performed Using the Same Software Solution
SUNNYVALE, Calif., June 16, 2021 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) ann... Devices, Oncology, Product Launch Accuray, RayStation, treatment planning, CyberKnife, Radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2021 Category: Pharmaceuticals Source Type: news
AI algorithm produces autosegmented contours for radiotherapy
Automatically segmented contours generated on CT scans by a deep-learning algorith...Read more on AuntMinnie.comRelated Reading:
Will physicians trust radiation therapy planned by AI?
Can 3D-printed shields protect patients during radiation therapy?
Hypofractionated radiotherapy helped England survive COVID-19
AI, radiomics predicts prostate cancer recurrence
AI can enhance MRI-guided radiation therapy plans (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 14, 2021 Category: Radiology Source Type: news
Accuray gets CE Mark for ClearRT imaging
Radiation oncology firm Accuray announced it has received the CE Mark for it...Read more on AuntMinnie.comRelated Reading:
Accuray appoints chief medical, technology officer
Accuray to tap Japanese market for ClearRT
Accuray nets FDA nod for ClearRT imaging technology
Accuray's fiscal Q1 revenue declines
Accuray partners with Brainlab in radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 11, 2021 Category: Radiology Source Type: news
Novel Gene Panel Predicts Who Can Skip RT in Early Breast Cancer Novel Gene Panel Predicts Who Can Skip RT in Early Breast Cancer
A novel 16-gene panel can both identify patients with a low risk of recurrence if they were to skip postsurgery radiation therapy, and predict which patients would be unlikely to benefit.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 8, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Elekta's new strategy to focus on growth and access to radiation therapy
Capital Markets Day presentations highlight opportunities and potential based on Elekta's strong position
STOCKHOLM, June 7, 2021 -- (Healthcare Sales & Marketing Network) -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO, Gustaf Salford, and members... Devices, Oncology Elekta, radiation therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2021 Category: Pharmaceuticals Source Type: news
Will physicians trust radiation therapy planned by AI?
Radiation oncologists may favor radiation therapy plans produced by a machine-learnin...Read more on AuntMinnie.comRelated Reading:
Can 3D-printed shields protect patients during radiation therapy?
Hypofractionated radiotherapy helped England survive COVID-19
AI, radiomics predicts prostate cancer recurrence
Physicians often miss rad therapy side effects
AI can enhance MRI-guided radiation therapy plans (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 4, 2021 Category: Radiology Source Type: news
Study finds lower mortality rate for men at high risk for death from prostate cancer who received early postoperative radiation therapy
(Brigham and Women's Hospital) A new, retrospective study focuses on men who have both high-grade prostate cancer that extends outside the prostate and/or has spread into the lymph nodes. For these men who are at high risk of dying from the disease, there was a significant reduction in the risk of death with adjuvant radiation therapy (aRT) use, suggesting that it should be offered to these men. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2021 Category: Cancer & Oncology Source Type: news
Upstate Cancer Center doctor to present results of clinical trial for small cell lung cancer at American Society of Clinical Oncology Annual Meeting
Evidence shows once daily radiation therapy treatment is effective. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - June 3, 2021 Category: Universities & Medical Training Tags: News Research Source Type: news
New findings offer improved therapy of early-stage, BRCA mutation-associated breast cancer
(Houston Methodist) A new treatment with potential to improve the outcomes for patients with hereditary BRCA mutations and high-risk, early-stage breast cancer appeared June 3 in the New England Journal of Medicine and will be presented June 6 at the 2021 ASCO Annual Meeting. These results represent the first time a PARP inhibitor has been shown to significantly reduce the risk of breast cancer returning in high-risk patients following completion of standard chemotherapy, surgery and radiation therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 3, 2021 Category: Cancer & Oncology Source Type: news
RaySearch releases update of RayStation software
Radiation therapy software developer RaySearch Laboratories has released 11A...Read more on AuntMinnie.comRelated Reading:
RaySearch, TAE Life Sciences partner on cancer therapy
RaySearch unveils new RayStation release
RaySearch, Varian partner to track radiation therapy
RaySearch inks Australian contract
Accuray, RaySearch treat 1st patients in Asia-Pacific (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 2, 2021 Category: Radiology Source Type: news
Stereotactic Radiotherapy for Early Stage NSCLC Stereotactic Radiotherapy for Early Stage NSCLC
A new review explores the current role of stereotactic body radiation therapy in the treatment of early stage non-small cell lung cancer and highlights recent research.Translational Lung Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 2, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Radiation Burn: What to Know
WebMD explains this side effect of radiation therapy and how to treat it. (Source: WebMD Health)
Source: WebMD Health - May 27, 2021 Category: Consumer Health News Source Type: news
RayCare 5A brings new features for radiation therapy management
STOCKHOLM, May 27, 2021 -- (Healthcare Sales & Marketing Network) -- RaySearch announces the release of a new version of RayCare®, the next-generation oncology information system. RayCare 5A* introduces a range of significant new features, including s... Devices, Oncology, Product Launch RaySearch Laboratories, RayCare, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 27, 2021 Category: Pharmaceuticals Source Type: news
Memorial Sloan Kettering Opening New Mesothelioma Clinical Trial
Memorial Sloan Kettering Cancer Center in New York City will begin recruiting soon for its latest clinical trial involving patients with malignant pleural mesothelioma and the expanded use of immunotherapy.
The single-center, phase I study will explore the effectiveness of pembrolizumab in combination with intensity-modulated pleural radiation therapy, known as IMPRINT, in treating unresectable disease.
Pembrolizumab, also known by the brand name Keytruda, was approved by the U.S. Food and Drug Administration in 2020 for treatment of a small subset of mesothelioma patients.
As a well-known immunotherapy drug, pemb...
Source: Asbestos and Mesothelioma News - May 26, 2021 Category: Environmental Health Authors: Matt Bardsley Source Type: news
